New drug reform likely to have restrictive impacts to domestic pharmaceutical sector

The Ministry of Health and Welfare has recently announced a major overhaul of the national health insurance program to broaden coverage of expenses related to the so-called four major illnesses designated by the Park Geun-hye government and readjust the prices of expensive drugs In Korea.

The four major illnesses are cancer, heart disease, cerebrovascular disease and 138 incurable diseases ...